Support

Support Options

Submit a Support Ticket

 

Tags: medicine

All Categories (1-20 of 57)

  1. [Illinois] Cancer Community Symposium 2012: A Sensitivity Scale for Targeting T Cells with Chimeric Antigen Receptors (CAR) and Bispecific T Cell Engagers (BiTE)

    09 May 2012 | Online Presentations | Contributor(s): Jennifer Stone

    Using a patients immune system to target cancer and maintain long-term surveillance is an attractive goal. Although T cells can respond potently to tumors, immune tolerance mechanisms often result...

    http://nanohub.org/resources/13941

  2. [Illinois] Cancer Community Symposium 2012: DriveRank: Discovering Patient-Specific Driver Mutations

    09 May 2012 | Online Presentations | Contributor(s): Jack Pu Hou

    One of the pressing challenges in cancer genomics is to distinguish driver mutations (i.e. mutations involved in tumorigenesis) and passenger mutations (i.e. functionally neutral mutations)....

    http://nanohub.org/resources/13939

  3. [Illinois] Cancer Community Symposium 2012: Elevated Estrogen Signaling Drives Tumorigenesis in a Novel Animal Model for Ovarian Epithelial Cancer

    09 May 2012 | Online Presentations | Contributor(s): Mary Jo Laws

    We generated a mouse model where aberrant estrogen receptor alpha (Esr1) signaling in the hypothalamo-pituitary-ovarian axis leads to ovarian tumorigenesis. In this model, termed Esr1d/d, the Esr1...

    http://nanohub.org/resources/13938

  4. Anne-Marie Fauser

    http://nanohub.org/members/56370

  5. Hadley Pattin

    http://nanohub.org/members/59723

  6. Heather Davies

    http://nanohub.org/members/55083

  7. [Illinois] B3SI 2012: Circumventing Barriers to Nanoparticle Delivery In Vivo

    02 Aug 2012 | Online Presentations | Contributor(s): Susan E. Clare

    http://nanohub.org/resources/14921

  8. [Illinois] Beckman Institute Graduate Student & Director's Seminar Series

    15 Jun 2013 | Series | Contributor(s): NanoBio Node

    The Beckman Institute Graduate Student Seminar Series presents the work of outstanding graduate students working in Beckman research groups. The seminars begin at Noon in Beckman Institute Room...

    http://nanohub.org/resources/18566

  9. [Illinois] Cancer Community Symposium 2012: An Integrated Approach to Cancer Research

    09 May 2012 | Online Presentations | Contributor(s): John F. McDonald

    The field of cancer biology is rapidly moving from an era of specialization to an era of integration. In my presentation, I will provide examples of the integration of molecular biology with...

    http://nanohub.org/resources/13937

  10. [Illinois] Cancer Community Symposium 2012: Arginine Glycine Aspartic Acid Motif Peptide Potentiates the Effect of Oxaliplatin Preventing Colon Cancer Metastasis, Binds to α5 β1 Integrin and Suppresses FAK/ERK/NF-kB Signaling

    09 May 2012 | Online Presentations | Contributor(s): Elvira de Mejia

    Arginine Glycine Aspartic Acid Motif Peptide Potentiates the Effect of Oxaliplatin Preventing Colon Cancer Metastasis, Binds to α5 β1 Integrin and Suppresses FAK/ERK/NF-kB Signaling Lunasin is a...

    http://nanohub.org/resources/13942

  11. [Illinois] Cancer Community Symposium 2012: Chemical Imaging for Histopathology: An Emerging Route for Molecular and Structural Analysis of Tissues

    09 May 2012 | Online Presentations | Contributor(s): Michael Walsh

    Mid-Infrared (IR) spectroscopic imaging is an emerging approach to derive chemical images from tissues based on their inherent biochemistry. Histologic diagnosis is the gold standard for...

    http://nanohub.org/resources/13946

  12. [Illinois] Cancer Community Symposium 2012: Closing Address and Awards

    09 May 2012 | Online Presentations | Contributor(s): Rohit Bhargava

    Jaeyun Sung announces the awards from the poster sessions. Dr. Rohit Bhargava provides the audience with reflections on the conference and thoughts going forward. Cancer Community At Illinois...

    http://nanohub.org/resources/13936

  13. [Illinois] Cancer Community Symposium 2012: Imaging Estrogen Receptors and Estrogen-Receptor Function in Breast Cancer by Positron Emission Tomography (PET): Improved Selection of Patients for Benefit from Endocrine Therapies

    09 May 2012 | Online Presentations | Contributor(s): John A. Katzenellenbogen

    The growth of many breast cancers is regulated by estrogens, and these cancers can be treated effectively with endocrine therapies (ET). Identifying patients who will benefit from ET, however,...

    http://nanohub.org/resources/13950

  14. [Illinois] Cancer Community Symposium 2012: Materials Science vs. Metastasis

    09 May 2012 | Online Presentations | Contributor(s): Daniel A. Heller

    Metastasis, the spread of cancer cells from a primary tumor to seed secondary tumors in distant sites, is one of the greatest challenges in cancer treatment today. For many patients, by the time...

    http://nanohub.org/resources/13947

  15. [Illinois] Cancer Community Symposium 2012: Micro-western Arrays for Identification of Novel Mechanisms Underlying Resistance of Cancer Cells to Chemotherapeutic Agents

    09 May 2012 | Online Presentations | Contributor(s): Richard B. Jones

    A fundamental goal in cancer treatment is the delivery of therapeutics in a manner that takes into consideration genetic differences between individuals. Genome-wide association analyses have...

    http://nanohub.org/resources/13940

  16. [Illinois] Cancer Community Symposium 2012: Panel Discussion

    09 May 2012 | Online Presentations

    Please join us for a panel discussion on the social impact of cancer and how it affects patients, providers, clinicians, and researchers alike. We are fortunate to feature Leslie Hammersmith...

    http://nanohub.org/resources/13945

  17. [Illinois] Cancer Community Symposium 2012: Speaking Up: The Patient Push for Accelerating Progress in Cancer Research

    09 May 2012 | Online Presentations | Contributor(s): Leslie Hammersmith

    Medical research empowers us to fight cancer, and advocacy empowers us to ensure that it addresses the needs of people affected by cancer. Advocacy helps us get through our cancer experiences,...

    http://nanohub.org/resources/13948

  18. [Illinois] Cancer Community Symposium 2012: T Cell Receptors For Potential Cancer Immunotherapy Applications: Single Chain T Cell Receptors Circumvent Mispairing with Endogenous TCR and Mediate T Cell Activity

    09 May 2012 | Online Presentations | Contributor(s): David H. Aggen

    To improve the immune response to cancer, gene therapy with tumor-specific T cell-receptors (TCRs) provides an attractive approach to effectively arm patients T cells for tumor cell destruction. A...

    http://nanohub.org/resources/13951

  19. [Illinois] Cancer Community Symposium 2012: The Inhibitory Effects of the Antifibrotic Drug Halofuginone on Uterine Leiomyoma Smooth Muscle Cells

    09 May 2012 | Online Presentations | Contributor(s): Faezeh Koohestani

    Uterine leiomyomas are the most prevalent benign tumors of the reproductive tract in women. Available treatments for leiomyomas are limited to surgical procedures or hormonal therapy, which are...

    http://nanohub.org/resources/13943

  20. [Illinois] Cancer Community Symposium 2012: The Man with the Crateriform Lesion: Advanced Squamous Cell Carcinoma

    09 May 2012 | Online Presentations | Contributor(s): Joseph Brancheck

    Cutaneous squamous cell carcinoma (SCC) is the second most common type of skin cancer in the United States and accounts for 20 percent of non-melanoma skin cancers; in addition, it is the second...

    http://nanohub.org/resources/13949

nanoHUB.org, a resource for nanoscience and nanotechnology, is supported by the National Science Foundation and other funding agencies. Any opinions, findings, and conclusions or recommendations expressed in this material are those of the author(s) and do not necessarily reflect the views of the National Science Foundation.